Most recently, a comprehensive study highlighted the critical involvement of TGF-β/Smad3 signaling during the process of obesity and demonstrated the beneficial effects of systemic blockade of this signaling from obesity, diabetes, and hepatic steatosis (Yadav et al., 2011). Here, TGFB1 is linked to diabetes mellitus.